179 related articles for article (PubMed ID: 27749218)
21. Risk of Cardiovascular Involvement in Patients with Primary Sjögren's Syndrome: a large-scale cross-sectional cohort study.
Cai X; Luo J; Wei T; Qin W; Wang X; Li X
Acta Reumatol Port; 2019; 44(1):71-77. PubMed ID: 31249278
[TBL] [Abstract][Full Text] [Related]
22. Serum CXCL4 increase in primary Sjögren's syndrome characterizes patients with microvascular involvement and reduced salivary gland infiltration and lymph node involvement.
Vettori S; Irace R; Riccardi A; Iacono D; Pellecchia L; Vicedomini L; Valentini G
Clin Rheumatol; 2016 Oct; 35(10):2591-6. PubMed ID: 27562035
[TBL] [Abstract][Full Text] [Related]
23. Risk of subclinical atherosclerosis in primary Sjogren's syndrome: A systematic review and meta-analysis.
Karakasis P; Patoulias D; Pamporis K; Stachteas P; Lefkou E; Bougioukas KI; Dimitroulas T; Fragakis N
Eur J Intern Med; 2024 Apr; 122():93-101. PubMed ID: 37977997
[TBL] [Abstract][Full Text] [Related]
24. Asymptomatic Atherosclerosis in Primary Sjögren Syndrome: Correlation Between Low Ankle Brachial Index and Autoantibodies Positivity.
Garcia AB; Dardin LP; Minali PA; Czapkowsky A; Ajzen SA; Trevisani VF
J Clin Rheumatol; 2016 Sep; 22(6):295-8. PubMed ID: 27556236
[TBL] [Abstract][Full Text] [Related]
25. Association between primary Sjogren's syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis.
Yong WC; Sanguankeo A; Upala S
Clin Rheumatol; 2019 Feb; 38(2):447-455. PubMed ID: 30178172
[TBL] [Abstract][Full Text] [Related]
26. Sjögren's syndrome in inflammatory rheumatic diseases: analysis of the leukocyte protein calprotectin in plasma and saliva.
Brun JG; Cuida M; Jacobsen H; Kloster R; Johannesen AC; Høyeraal HM; Jonsson R
Scand J Rheumatol; 1994; 23(3):114-8. PubMed ID: 8016580
[TBL] [Abstract][Full Text] [Related]
27. Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sjögren's syndrome: a retrospective study in China.
Yang L; Liang Y; Pu J; Cai L; Gao R; Han F; Chang K; Pan S; Wu Z; Zhang Y; Wang Y; Song J; Wu H; Tang J; Wang X
Immunol Lett; 2024 Jun; 267():106865. PubMed ID: 38705483
[TBL] [Abstract][Full Text] [Related]
28. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
[TBL] [Abstract][Full Text] [Related]
29. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
Shi L; Fu Q; Chen N; Liu R; Zheng Y
Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
[TBL] [Abstract][Full Text] [Related]
30. Fatigue in primary Sjögren's syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study.
Davies K; Mirza K; Tarn J; Howard-Tripp N; Bowman SJ; Lendrem D; ; Ng WF
Rheumatol Int; 2019 Nov; 39(11):1867-1873. PubMed ID: 31250166
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of abnormal ankle brachial index in patients with primary Sjogren's syndrome.
Rachapalli SM; Kiely PD; Bourke BE
Clin Rheumatol; 2009 May; 28(5):587-90. PubMed ID: 19205787
[TBL] [Abstract][Full Text] [Related]
32. Circulating markers of inflammation are related to carotid artery atherosclerosis.
Larsson PT; Hallerstam S; Rosfors S; Wallén NH
Int Angiol; 2005 Mar; 24(1):43-51. PubMed ID: 15876998
[TBL] [Abstract][Full Text] [Related]
33. The impact of primary Sjögren's syndrome on female sexual function.
van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H
Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072
[TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon.
Willeke P; Schlüter B; Schotte H; Domschke W; Gaubitz M; Becker H
Semin Arthritis Rheum; 2009 Dec; 39(3):197-202. PubMed ID: 18571695
[TBL] [Abstract][Full Text] [Related]
35. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
36. Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome.
Han M; Li Y; Liu S; Jiang S; Yuan L; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2018 Oct; 38(10):452-456. PubMed ID: 30256702
[TBL] [Abstract][Full Text] [Related]
37. [Screening for serum specific biomarkers in patients with primary Sjögren's syndrome and interstitial lung disease using proteomic fingerprint techniques].
Li YH; Sun XL; He J; Jia RL; Yang DY; Zhang XW; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):240-3. PubMed ID: 22516996
[TBL] [Abstract][Full Text] [Related]
38. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
[TBL] [Abstract][Full Text] [Related]
39. Adropin Serum Levels in Patients with Primary Sjögren's Syndrome.
Danolić MJ; Perković D; Petrić M; Barišić I; Gugo K; Božić J
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572509
[TBL] [Abstract][Full Text] [Related]
40. Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors.
Gerli R; Vaudo G; Bocci EB; Schillaci G; Alunno A; Luccioli F; Hijazi R; Mannarino E; Shoenfeld Y
Arthritis Care Res (Hoboken); 2010 May; 62(5):712-8. PubMed ID: 20191479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
